Table 2.
Demographic breakdown of patients enrolled in pilot clinical study.
| Characteristic | Biopsies |
|---|---|
| Number of Patients | |
| Ultrasound (US) biopsy | 37 |
| Mammoplasty biopsy | 6 |
| Patient Demographics | |
| Average Age (range) | 55 (25–79) |
| Average BMI (range) | 30 (18–54.4) |
| Pathology Breakdown | |
| Malignant (US only) | 27 (73%) |
| Benign (US only) | 10 (27%) |
| Receptor Status (malignant only) | |
| ER+,− | 22 (81%), 5 (19%) |
| PR+,− | 19 (70%), 8 (30%) |
| Her2+,− | 5 (19%), 22 (81%) |
| TNBC | 4 (15%) |
| Menopausal Status | |
| Pre-menopause | 14 (37%) |
| Peri-menopause | 1 (2%) |
| Post-menopause | 23 (61%) |
| Breast Density | |
| Fatty | 4 (11%) |
| Scattered Fibroglandular | 13 (35%) |
| Heterogeneous Density | 15 (41%) |
| Extremely Dense | 5 (13%) |